Supplemental material
Cancer Biology & Therapy
Volume 23, 2022 - Issue 1
Open access
3,716
Views
0
CrossRef citations to date
0
Altmetric
Research Paper
Repeated treatments of Capan-1 cells with PARP1 and Chk1 inhibitors promote drug resistance, migration and invasion
Ne Guoa Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China;b University of Chinese Academy of Sciences, Beijing, Chinahttps://orcid.org/0000-0002-1740-8913View further author information
, Meng-Zhu Lia Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China;b University of Chinese Academy of Sciences, Beijing, ChinaView further author information
, Li-Min Wanga Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China;b University of Chinese Academy of Sciences, Beijing, ChinaView further author information
, Hua-Dong Chena Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China;b University of Chinese Academy of Sciences, Beijing, ChinaView further author information
, Shan-Shan Songa Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, ChinaView further author information
, Ze-Hong Miaoa Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China;b University of Chinese Academy of Sciences, Beijing, ChinaView further author information
& Jin-Xue Hea Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China;b University of Chinese Academy of Sciences, Beijing, ChinaCorrespondence[email protected]
[email protected]
View further author information
show all[email protected]
View further author information
Pages 69-82
|
Received 24 Apr 2021, Accepted 23 Dec 2021, Published online: 09 Jan 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.